Bladder symptoms in multiple sclerosis (MS) are common and distressing but also highly
amenable to treatment. A meeting of stakeholders involved in patients' continence care …

Introduction Sacral neuromodulation (SNM) has been used in carefully selected patients
with neurogenic lower urinary tract dysfunctions (nLUTD) for over two decades. Methods …

CONTEXT: Treatment of neurogenic lower urinary tract dysfunction (LUTD) is a challenge,
because conventional therapies often fail. Sacral neuromodulation (SNM) has become a …

Lower urinary tract (LUT) dysfunction is common in patients with multiple sclerosis and is a
major negative influence on the quality of life of these patients. The most commonly reported …

Aims Electrostimulation is an established therapeutic option for neurogenic urinary
disorders. The aim of this study was to investigate the efficacy of the noninvasive technique …

Besides immunomodulation and immunosuppression, the specific treatment of symptoms is
an essential component of the overall management of multiple sclerosis (MS). Symptomatic …

Aims Pudendal nerve stimulation has beneficial effects on numerous pelvic floor function
impairments such as urinary and/or fecal incontinence, retention, and constipation. In …

The authors concluded that the evidence did not allow definitive conclusions on the relative
benefit and harm of different treatments to achieve similar results. High-quality research was …

Objectives: To examine the acute effects of different modes of dorsal penile nerve
stimulation on detrusor hyperreflexia, bladder capacity and bladder compliance in spinal …

OBJECTIVES: To determine the variables that affect the cure rate in patients with urge
incontinence treated with sacral neuromodulation. METHODS: This prospective analysis of …